May 12, 2025
Comments to OMB with Recommendations for Deregulation
- Withdrawal of FDA Proposed Rule re: Reclassification of Certain Antimicrobial Wound Dressings
- Changes to Prior Authorization processes
- Lessening of burdens within Medicare’s Therapeutic Shoe Program for Patients with Diabetes
- Fixes to problematic payment provisions for CTPs in the Hospital Outpatient Prospective Payment System
- Expanded adoption of real-world evidence (RWE) and updates to Coverage with Evidence Development